To support its customers' strong growth, in particular in the sports and consumer goods markets, Arkema will increase its global manufacturing capacity for Pebax® elastomers by approximately 25 percent through an investment at its Serquigny plant in France.
Arkema announces a 25 percent increase in its global Pebax elastomer production capacity by investing in Serquigny in France. This investment will notably enable increased production of the bio-circular Pebax Rnew® and traditional Pebax ranges. This new capacity will produce a variety of highly specialized grades to meet growing demand in numerous demanding applications thanks to the lightweight, flexibility and excellent energy return of these materials. These properties are particularly appreciated in sports equipment, such as soles for running shoes, ski boots or technical textile, in consumer goods such as smartphones and flexible screens, as well as in other markets such as medical equipment.
Iš atsinaujinančių ricinos sėklų pagamintos pažangios „Pebax Rnew“ biologinės{0}}apvalios medžiagos yra tvarus sprendimas mūsų klientams, kuriems vis labiau rūpi tvarumas ir socialinė atsakomybė. Palyginti su kitais rinkoje esančiais elastomerais, šių medžiagų anglies pėdsakas yra iki 50 procentų mažesnis ir gali būti visiškai perdirbamas. Be to, ši investicija, kurią planuojama pradėti įgyvendinti 2023 m. viduryje, dėl proceso optimizavimo sumažins vandens suvartojimą svetainėje 25 proc.
"We are very excited to commit to an expansion in our Pebax elastomers capacity" said Erwoan Pezron, senior vice-president of Arkema's High Performance Polymers Business Line. "The Serquigny plant has a long proven legacy in the production of these advanced materials, and we are delighted to add this new capacity to support our customers' growing demand for high-performance sustainable materials. We will also continue to produce many of these materials at our Birdsboro plant in Pennsylvania."
